KALA BIO Adds Healthcare Expert Yenvy Truong to Advisory Team

NEW YORK, Sept. 17, 2026 /CourierPR/ -- KALA BIO, Inc., a clinical-stage biopharmaceutical company, has bolstered its advisory team by welcoming Yenvy Truong, founder of The LSM Group, to provide strategic guidance. Truong’s extensive experience in healthcare operations and her track record of founding, scaling, and advising healthcare and life sciences companies make her a valuable asset to KALA BIO’s growth strategy.

Truong, who has spent nearly two decades in the healthcare sector, has built and operated diagnostic laboratories and advised on mergers, acquisitions, and growth financings. Her expertise spans genomics, longevity, remote patient monitoring, digital musculoskeletal care, and metabolic medicine. KALA BIO is focused on expanding its business in diagnostics, genetic testing, and other areas of preventive and connected health, all enhanced by artificial intelligence (AI).

Truong expressed enthusiasm about her new role. "KALA BIO has a clear plan to grow its business and expand where it makes sense. I'm looking forward to working with Avi and the team to identify opportunities that fit that plan and to help build long-term value," she stated.

KALA BIO, Inc. is building a dedicated, on-premises AI infrastructure platform for the biotechnology industry. The company's dual strategy combines a proprietary biologics pipeline, including its mesenchymal stem cell secretome (MSC-S) platform and FDA Orphan Drug- and Fast Track-designated product candidates, with a scalable AI platform-as-a-service business designed to deploy secure, purpose-built AI solutions directly within biotech and pharmaceutical client environments.

The company's exclusive worldwide license for the Researgency AI research platform from Younet enables KALA BIO to serve as the dedicated AI infrastructure partner for the biotechnology industry, enabling organizations of all sizes to unlock the value of their proprietary biological data without surrendering control.

KALA BIO's focus on enterprise security, real-time performance, and seamless integration positions it at the forefront of innovation in the life sciences AI sector. The company believes the future of biomedical innovation lies in agentic systems.

With the addition of Truong to its advisory team, KALA BIO aims to leverage her extensive experience to drive strategic growth and identify key opportunities for expansion.